Radiotherapy vs chemotherapy for low-grade gliomas stratified for genetic 1p loss: efficacy and quality of life benefits

低级别胶质瘤的放疗与化疗针对遗传 1p 丢失进行分层：疗效和生活质量益处

• 批准号: nhmrc : 509094
• 负责人: Dr David Walker
• 金额: $ 27.36万
• 依托单位: The University of Melbourne
• 依托单位国家: 澳大利亚
• 项目类别: NHMRC Project Grants
• 财政年份: 2008
• 资助国家: 澳大利亚
• 起止时间: 2008-01-01 至 2012-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/radiotherapy-vs-chemotherapy-life-benefits/97674
• 关键词: Radiotherapy; vs; chemotherapy; low; grade

Low-grade glioma is an uncommon malignant brain tumour. Surgery, radiotherapy and chemotherapy delay growth of this tumour, but cure is uncommon. Currently the goal of treatment is to control tumour growth for as long as possible whilst maintaining quality of life. This study compares treatment with radiotherapy with a new form of chemotherapy to see which treatment controls tumour growth most effectively, which produces the least side effects and which results in the better quality of life.

低度恶性胶质瘤是一种罕见的恶性脑肿瘤。手术、放疗和化疗可以延缓这种肿瘤的生长，但治愈并不常见。目前治疗的目标是尽可能长时间地控制肿瘤生长，同时保持生活质量。这项研究将放疗与新型化疗进行比较，看看哪种治疗最有效地控制肿瘤生长，产生的副作用最少，并且可以提高生活质量。